UBE2Q1 and ovarian serous adenocarcinoma: An AUC value of 0.654 (p value = 1.2e-04) suggests a convincing potential of UBE2Q1 as a predictive biomarker of clinical utility to predict relapse free survival of serous ovarian cancer patients of later stages/grades in response to platin/taxane therapy.